Concepts (239)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Growth Disorders | 6 | 2023 | 645 | 1.790 |
Why?
|
Tuberculosis, Multidrug-Resistant | 6 | 2018 | 912 | 1.120 |
Why?
|
Family Characteristics | 3 | 2020 | 1000 | 1.000 |
Why?
|
Child Nutrition Disorders | 3 | 2021 | 149 | 0.970 |
Why?
|
Malnutrition | 3 | 2020 | 625 | 0.950 |
Why?
|
Rwanda | 11 | 2023 | 703 | 0.860 |
Why?
|
Madagascar | 11 | 2023 | 117 | 0.860 |
Why?
|
Child Development | 5 | 2023 | 2223 | 0.830 |
Why?
|
Lost to Follow-Up | 3 | 2020 | 105 | 0.810 |
Why?
|
Rural Health Services | 6 | 2019 | 379 | 0.780 |
Why?
|
Rural Population | 16 | 2023 | 2210 | 0.780 |
Why?
|
Child, Orphaned | 1 | 2021 | 55 | 0.750 |
Why?
|
Antitubercular Agents | 7 | 2018 | 1320 | 0.720 |
Why?
|
Parturition | 1 | 2023 | 441 | 0.690 |
Why?
|
Tuberculosis, Pulmonary | 3 | 2018 | 810 | 0.680 |
Why?
|
Geographic Information Systems | 1 | 2020 | 281 | 0.640 |
Why?
|
Patient Dropouts | 2 | 2018 | 421 | 0.540 |
Why?
|
Minority Groups | 1 | 2023 | 1223 | 0.540 |
Why?
|
Parenting | 2 | 2021 | 679 | 0.540 |
Why?
|
Developmental Disabilities | 2 | 2020 | 1456 | 0.490 |
Why?
|
Language | 1 | 2023 | 1471 | 0.480 |
Why?
|
Russia | 4 | 2018 | 408 | 0.470 |
Why?
|
Disease Transmission, Infectious | 1 | 2018 | 547 | 0.430 |
Why?
|
Mycobacterium tuberculosis | 6 | 2016 | 1832 | 0.420 |
Why?
|
Communicable Disease Control | 1 | 2018 | 857 | 0.400 |
Why?
|
Infant | 20 | 2023 | 35136 | 0.390 |
Why?
|
Guatemala | 5 | 2023 | 142 | 0.380 |
Why?
|
HIV Infections | 6 | 2021 | 16718 | 0.380 |
Why?
|
Health Services Research | 1 | 2018 | 1836 | 0.370 |
Why?
|
Child, Preschool | 21 | 2023 | 41006 | 0.350 |
Why?
|
Tuberculosis | 5 | 2012 | 1912 | 0.340 |
Why?
|
Ebolavirus | 3 | 2016 | 263 | 0.330 |
Why?
|
Sampling Studies | 2 | 2020 | 623 | 0.320 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2020 | 2020 | 0.320 |
Why?
|
Sputum | 1 | 2010 | 476 | 0.310 |
Why?
|
Hemorrhagic Fever, Ebola | 3 | 2016 | 428 | 0.280 |
Why?
|
Alcoholism | 1 | 2016 | 1906 | 0.260 |
Why?
|
Maternal Health Services | 2 | 2020 | 455 | 0.250 |
Why?
|
Mentors | 2 | 2020 | 631 | 0.240 |
Why?
|
Child | 22 | 2023 | 77709 | 0.230 |
Why?
|
Infant, Newborn | 11 | 2021 | 25625 | 0.230 |
Why?
|
Socioeconomic Factors | 5 | 2023 | 7785 | 0.230 |
Why?
|
Aflatoxins | 1 | 2023 | 10 | 0.230 |
Why?
|
Health Status | 1 | 2017 | 4034 | 0.230 |
Why?
|
Homeless Persons | 1 | 2002 | 8 | 0.220 |
Why?
|
Bacterial Typing Techniques | 2 | 2002 | 256 | 0.220 |
Why?
|
Urban Population | 2 | 2010 | 2021 | 0.220 |
Why?
|
Alcohol Drinking | 2 | 2012 | 3966 | 0.210 |
Why?
|
Adolescent | 17 | 2022 | 85781 | 0.210 |
Why?
|
Diarrhea | 2 | 2021 | 1348 | 0.200 |
Why?
|
Capacity Building | 2 | 2021 | 248 | 0.200 |
Why?
|
Young Adult | 14 | 2022 | 56430 | 0.200 |
Why?
|
Humans | 51 | 2023 | 744343 | 0.190 |
Why?
|
Operations Research | 1 | 2020 | 23 | 0.190 |
Why?
|
Peru | 2 | 2021 | 881 | 0.190 |
Why?
|
Public Health Practice | 1 | 2002 | 218 | 0.180 |
Why?
|
Female | 34 | 2023 | 380194 | 0.180 |
Why?
|
Quality Improvement | 3 | 2021 | 3749 | 0.180 |
Why?
|
Patient Acceptance of Health Care | 4 | 2019 | 3022 | 0.180 |
Why?
|
Adult | 25 | 2023 | 214055 | 0.170 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25043 | 0.170 |
Why?
|
Wasting Syndrome | 1 | 2019 | 101 | 0.170 |
Why?
|
Clone Cells | 1 | 2002 | 1692 | 0.170 |
Why?
|
Follow-Up Studies | 6 | 2020 | 39050 | 0.160 |
Why?
|
Health Surveys | 2 | 2020 | 4037 | 0.160 |
Why?
|
Infant, Low Birth Weight | 2 | 2020 | 850 | 0.160 |
Why?
|
Male | 31 | 2023 | 350118 | 0.160 |
Why?
|
Home Childbirth | 1 | 2018 | 51 | 0.160 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2020 | 392 | 0.150 |
Why?
|
Education, Nursing, Continuing | 1 | 2017 | 75 | 0.150 |
Why?
|
Maternal Mortality | 2 | 2018 | 310 | 0.150 |
Why?
|
Midwifery | 1 | 2018 | 132 | 0.140 |
Why?
|
Uganda | 1 | 2021 | 1243 | 0.140 |
Why?
|
Disease Outbreaks | 2 | 2002 | 1772 | 0.140 |
Why?
|
Fees and Charges | 1 | 2017 | 195 | 0.140 |
Why?
|
Perinatal Care | 1 | 2018 | 227 | 0.140 |
Why?
|
Retrospective Studies | 10 | 2023 | 77449 | 0.140 |
Why?
|
Nucleoproteins | 1 | 2016 | 115 | 0.130 |
Why?
|
Middle Aged | 18 | 2020 | 213383 | 0.130 |
Why?
|
Logistic Models | 5 | 2019 | 13408 | 0.130 |
Why?
|
Mass Screening | 2 | 2010 | 5255 | 0.130 |
Why?
|
Child Mortality | 1 | 2017 | 198 | 0.120 |
Why?
|
Unsafe Sex | 1 | 2016 | 220 | 0.120 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2015 | 224 | 0.120 |
Why?
|
Anthropometry | 1 | 2018 | 1350 | 0.120 |
Why?
|
Infant, Premature | 2 | 2020 | 2044 | 0.110 |
Why?
|
Child Health Services | 1 | 2019 | 667 | 0.110 |
Why?
|
Feasibility Studies | 2 | 2020 | 5078 | 0.110 |
Why?
|
Lesotho | 3 | 2022 | 70 | 0.110 |
Why?
|
RNA, Viral | 3 | 2016 | 2902 | 0.110 |
Why?
|
Men's Health | 1 | 2012 | 73 | 0.110 |
Why?
|
Health Services | 1 | 2017 | 758 | 0.100 |
Why?
|
Health Facilities | 1 | 2016 | 573 | 0.100 |
Why?
|
Body Height | 1 | 2018 | 1577 | 0.100 |
Why?
|
Seroepidemiologic Studies | 2 | 2023 | 401 | 0.100 |
Why?
|
Antigens, Viral | 1 | 2015 | 1035 | 0.100 |
Why?
|
Cluster Analysis | 3 | 2010 | 2715 | 0.100 |
Why?
|
Poverty | 3 | 2021 | 2660 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 1049 | 0.100 |
Why?
|
Malaria | 1 | 2021 | 1239 | 0.100 |
Why?
|
Epidemics | 1 | 2016 | 523 | 0.090 |
Why?
|
Family | 1 | 2021 | 3147 | 0.090 |
Why?
|
Risk-Taking | 1 | 2016 | 986 | 0.090 |
Why?
|
Point-of-Care Systems | 2 | 2016 | 1177 | 0.090 |
Why?
|
Mothers | 1 | 2020 | 2165 | 0.090 |
Why?
|
Prevalence | 3 | 2022 | 15226 | 0.090 |
Why?
|
Directly Observed Therapy | 1 | 2010 | 137 | 0.090 |
Why?
|
Primary Health Care | 3 | 2022 | 4558 | 0.090 |
Why?
|
Attitude to Health | 2 | 2016 | 2052 | 0.090 |
Why?
|
Respiratory Tract Infections | 1 | 2017 | 961 | 0.090 |
Why?
|
Brazil | 2 | 2010 | 1270 | 0.080 |
Why?
|
Risk Factors | 7 | 2022 | 72290 | 0.080 |
Why?
|
Laboratories | 2 | 2002 | 463 | 0.080 |
Why?
|
Prisoners | 1 | 2012 | 297 | 0.080 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4751 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2265 | 0.080 |
Why?
|
Pregnancy | 4 | 2023 | 29144 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2018 | 1956 | 0.080 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.080 |
Why?
|
Aged | 12 | 2023 | 163280 | 0.080 |
Why?
|
Nurses | 1 | 2017 | 2461 | 0.080 |
Why?
|
Glycoproteins | 1 | 2016 | 2263 | 0.080 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12245 | 0.080 |
Why?
|
Contact Tracing | 3 | 2010 | 273 | 0.080 |
Why?
|
Health Services Accessibility | 3 | 2021 | 5137 | 0.070 |
Why?
|
Diabetes Mellitus | 2 | 2022 | 5751 | 0.070 |
Why?
|
Developing Countries | 2 | 2017 | 2815 | 0.070 |
Why?
|
Income | 1 | 2015 | 1913 | 0.070 |
Why?
|
Hospitals, District | 2 | 2020 | 106 | 0.070 |
Why?
|
Mental Health | 1 | 2020 | 3019 | 0.070 |
Why?
|
Sierra Leone | 2 | 2016 | 166 | 0.070 |
Why?
|
Diagnostic Errors | 2 | 2002 | 1257 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8480 | 0.060 |
Why?
|
Insurance, Health | 1 | 2017 | 2494 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2002 | 768 | 0.060 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2029 | 0.060 |
Why?
|
Equipment Contamination | 2 | 2002 | 185 | 0.060 |
Why?
|
Hospitals | 1 | 2018 | 3952 | 0.060 |
Why?
|
HIV | 1 | 2012 | 1604 | 0.060 |
Why?
|
Aged, 80 and over | 5 | 2018 | 57776 | 0.060 |
Why?
|
Program Evaluation | 1 | 2012 | 2488 | 0.060 |
Why?
|
Incidence | 4 | 2021 | 20947 | 0.060 |
Why?
|
Aflatoxin B1 | 1 | 2023 | 18 | 0.060 |
Why?
|
Streptomycin | 1 | 2002 | 69 | 0.060 |
Why?
|
Zea mays | 1 | 2023 | 105 | 0.050 |
Why?
|
Antibiotics, Antitubercular | 1 | 2002 | 104 | 0.050 |
Why?
|
Bioreactors | 1 | 2023 | 236 | 0.050 |
Why?
|
Treatment Failure | 2 | 2018 | 2618 | 0.050 |
Why?
|
Isoniazid | 1 | 2002 | 274 | 0.050 |
Why?
|
Telemedicine | 1 | 2018 | 2872 | 0.050 |
Why?
|
Sentinel Surveillance | 1 | 2002 | 281 | 0.050 |
Why?
|
Medication Adherence | 1 | 2012 | 2063 | 0.050 |
Why?
|
Health Promotion | 1 | 2012 | 2205 | 0.050 |
Why?
|
Cities | 1 | 2022 | 513 | 0.050 |
Why?
|
Nutritional Status | 2 | 2019 | 1609 | 0.050 |
Why?
|
Emigration and Immigration | 1 | 2002 | 404 | 0.040 |
Why?
|
Regional Medical Programs | 1 | 2019 | 71 | 0.040 |
Why?
|
Capreomycin | 1 | 2018 | 14 | 0.040 |
Why?
|
Cohort Studies | 2 | 2020 | 40561 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2016 | 63114 | 0.040 |
Why?
|
Amikacin | 1 | 2018 | 48 | 0.040 |
Why?
|
Marital Status | 1 | 2020 | 437 | 0.040 |
Why?
|
Kanamycin | 1 | 2018 | 64 | 0.040 |
Why?
|
Clofazimine | 1 | 2018 | 33 | 0.040 |
Why?
|
Hospitals, Rural | 1 | 2020 | 172 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1769 | 0.040 |
Why?
|
Cognition | 1 | 2015 | 6770 | 0.040 |
Why?
|
Carbapenems | 1 | 2018 | 118 | 0.040 |
Why?
|
Maternal Age | 1 | 2020 | 802 | 0.040 |
Why?
|
Sanitation | 1 | 2018 | 93 | 0.040 |
Why?
|
Immunization | 1 | 2022 | 1256 | 0.040 |
Why?
|
Genotype | 3 | 2016 | 12951 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15165 | 0.040 |
Why?
|
Fluoroquinolones | 1 | 2018 | 310 | 0.030 |
Why?
|
Anti-HIV Agents | 1 | 2012 | 4256 | 0.030 |
Why?
|
Time Factors | 2 | 2012 | 40075 | 0.030 |
Why?
|
Growth | 1 | 2018 | 376 | 0.030 |
Why?
|
Organizations | 1 | 2016 | 170 | 0.030 |
Why?
|
Massachusetts | 3 | 2002 | 8663 | 0.030 |
Why?
|
Research Personnel | 1 | 2020 | 573 | 0.030 |
Why?
|
India | 1 | 2021 | 2197 | 0.030 |
Why?
|
Smoking | 1 | 2012 | 8987 | 0.030 |
Why?
|
Seasons | 1 | 2021 | 1493 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 722 | 0.030 |
Why?
|
Heart Failure | 2 | 2020 | 10900 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2020 | 13989 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2017 | 11725 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2022 | 21746 | 0.030 |
Why?
|
Quality of Health Care | 2 | 2019 | 4371 | 0.030 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.030 |
Why?
|
Antibodies, Viral | 1 | 2023 | 3176 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8388 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2019 | 2453 | 0.030 |
Why?
|
Immunoassay | 1 | 2015 | 752 | 0.020 |
Why?
|
Birth Weight | 1 | 2019 | 2069 | 0.020 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 21683 | 0.020 |
Why?
|
Linear Models | 1 | 2021 | 5952 | 0.020 |
Why?
|
Checklist | 1 | 2017 | 833 | 0.020 |
Why?
|
Africa South of the Sahara | 1 | 2013 | 724 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15540 | 0.020 |
Why?
|
Microbial Sensitivity Tests | 1 | 2016 | 1877 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2016 | 14722 | 0.020 |
Why?
|
Vaccination | 1 | 2022 | 3278 | 0.020 |
Why?
|
Boston | 1 | 2002 | 9313 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2593 | 0.020 |
Why?
|
Health Care Costs | 1 | 2002 | 3209 | 0.020 |
Why?
|
Quality Indicators, Health Care | 1 | 2019 | 1831 | 0.020 |
Why?
|
Culture | 1 | 2012 | 633 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6489 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2017 | 2266 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9849 | 0.020 |
Why?
|
Body Weight | 1 | 2018 | 4669 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8340 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3508 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2559 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 941 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9146 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2016 | 1917 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9959 | 0.020 |
Why?
|
Inflammation | 1 | 2023 | 10638 | 0.010 |
Why?
|
Health Personnel | 1 | 2016 | 3218 | 0.010 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1715 | 0.010 |
Why?
|
DNA Fingerprinting | 1 | 2002 | 112 | 0.010 |
Why?
|
Patient Compliance | 1 | 2012 | 2684 | 0.010 |
Why?
|
Health Behavior | 1 | 2012 | 2636 | 0.010 |
Why?
|
Echocardiography | 1 | 2013 | 5102 | 0.010 |
Why?
|
Molecular Epidemiology | 1 | 2002 | 468 | 0.010 |
Why?
|
Obesity | 1 | 2022 | 12745 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2012 | 3396 | 0.010 |
Why?
|
False Positive Reactions | 1 | 2002 | 981 | 0.010 |
Why?
|
Age Factors | 1 | 2016 | 18370 | 0.010 |
Why?
|
Sex Factors | 1 | 2012 | 10397 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5319 | 0.010 |
Why?
|
Specimen Handling | 1 | 2002 | 694 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1465 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 19905 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29063 | 0.010 |
Why?
|
Concepts
(239)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(46)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_